Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will highlight its innovative offering of products and services for clinical research and specialty diagnostics during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo held in Anaheim, California, July 25 - 29, 2010.
“Building on the strength of our highly recognized brands for clinical research and combining them into an easy-to-use workflow demonstrates for our customers the benefit of working with a single, comprehensive supplier.”
Thermo Fisher will introduce a substantially improved liquid chromatography/mass spectrometry (LC/MS) workflow for immunosuppressant analysis designed to improve productivity in clinical research applications. The seamless integration of instruments, software, consumables and reagents significantly reduces sample preparation time, improves overall performance and provides a total workflow supported by a single supplier. This workflow will be adapted to the analysis of a number of drugs, as well as vitamins and steroids. For more information, visit Booth 2415 at the Anaheim Convention Center.
"This year at AACC, we are highlighting how our scale and depth of capabilities are meeting increasing demand in clinical research and specialty diagnostics markets," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "Building on the strength of our highly recognized brands for clinical research and combining them into an easy-to-use workflow demonstrates for our customers the benefit of working with a single, comprehensive supplier."